drugset / Trial / NCT01773083

Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma

NCT01773083

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this international multi-center double-blind randomized placebo-controlled trial is to determine the effect of nebulized heparin, compared to placebo, on the number of ventilator-free days at day 28, in burn patients with confirmed inhalation trauma requiring mechanical ventilation.

Timeline

Start
2013-10
Primary completion
2016-10
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 25000 iu Other

Indications